Study to Compare Capecitabine Combined With Dacarbazine(CAPDTIC) Versus Capecitabine Combined Temozolomide(CAPTEM) in Advanced and Metastatic Gastrointestinal Pancreatic and Esophageal Neuroendocrine Tumor
Clinical trial NCT03279601 · UNKNOWN
Trial details
- NCT number
- NCT03279601
- Sponsor
- Peking University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-01
- Primary completion
- 2019-09-01
- Enrollment
- 148
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.